Thursday, July 18, 2013

China - Now UCB get a visit

By Ben Deighton and Ben Hirschler

BRUSSELS/LONDON | Thu Jul 18, 2013 6:05pm BST

(Reuters) - Belgian drugmaker UCB (UCB.BR) has been visited by Chinese authorities as the country widens investigations into bribery by drugmakers, following allegations against Britain's GlaxoSmithKline (GSK.L).

A spokesman for UCB said on Thursday that officials were also investigating a number of other drug companies with operations in the country, although he did not identify them.

No comments: